Top 100 Contractors in NAICS 325412: Pharmaceutical Preparation Manufacturing, Aug 2025–Jul 2026
Parent companies by net contract obligations Aug 1, 2025 – Jul 31, 2026 Code page on GovTribe
The latest 12 months. See the newest fiscal year's list: Top Contractors in NAICS 325412: Pharmaceutical Preparation Manufacturing, FY2025.
The top 10 won 95% of NAICS 325412 contract dollars from August 2025 through July 2026
Ranking facts
- Contract obligations
- $13,114,408,815 Net of deobligations, by contracts coded NAICS 325412
- Contractors
- 257 Parent companies with an obligation
- Largest contractor
- Mckesson Corporation $12 billion, 90.0% of obligations
- Data as of
Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)
Full ranking
| Rank | Contractor | Net obligations | Share | Trend |
|---|---|---|---|---|
| 1 | $12,015,110,957 | |||
| 2 |
Emergent Biosolutions Inc.
Top agencies
|
$118,254,297 | ||
| 3 |
Phlow Corp.
Top agencies
|
$113,641,157 | ||
| 4 | $106,483,712 | |||
| 5 | $65,536,123 | |||
| 6 | $55,273,060 | |||
| 7 | $50,162,464 | |||
| 8 |
Meridian Medical Technologies LLC
Top agencies
|
$46,041,826 | ||
| 9 | $42,247,141 | |||
| 10 |
Roche Holdings Inc.
|
$38,863,659 | ||
| 11 | $38,563,113 | |||
| 12 | $36,255,004 | |||
| 13 | $33,392,936 | |||
| 14 | $33,119,794 | |||
| 15 |
Novartis Pharmaceuticals Corporation
|
$31,536,941 | ||
| 16 | $29,998,678 | |||
| 17 | $25,718,673 | |||
| 18 |
Sagent Pharmaceuticals Inc.
Top agencies
|
$16,638,758 | ||
| 19 | $16,635,101 | |||
| 20 | $15,590,937 | |||
| 21 | $11,293,751 | |||
| 22 | $9,827,897 | |||
| 23 | $9,535,684 | |||
| 24 | $9,412,734 | |||
| 25 | $8,700,000 | |||
| 26 |
RLS (USA) Inc.
|
$8,497,167 | ||
| 27 | $8,099,930 | |||
| 28 |
Fresenius Medical Care Holdings Inc.
|
$8,094,273 | ||
| 29 | $7,615,500 | |||
| 30 | $6,962,890 | |||
| 31 |
Siemens Corporation
|
$6,080,223 | ||
| 32 | $5,236,992 | |||
| 33 | $4,974,870 | |||
| 34 | $4,507,247 | |||
| 35 | $4,415,845 | |||
| 36 |
Bracco Diagnostics Inc.
|
$4,276,720 | ||
| 37 | $3,696,281 | |||
| 38 | $3,627,452 | |||
| 39 |
Merck & Co. Inc.
|
$2,945,487 | ||
| 40 |
Sanofi Pasteur Inc.
|
$2,891,688 | ||
| 41 | $2,651,492 | |||
| 42 | $2,468,330 | |||
| 43 | $2,340,134 | |||
| 44 | $2,097,799 | |||
| 45 | $2,049,579 | |||
| 46 | $1,844,468 | |||
| 47 |
MRIGLOBAL
Top agencies
|
$1,826,389 | ||
| 48 |
American Regent Inc
Top agencies
|
$1,804,958 | ||
| 49 | $1,733,234 | |||
| 50 |
Jubilant Hollisterstier LLC
|
$1,674,707 | ||
| 51 |
Curia Global Inc.
Top agencies
|
$1,548,154 | ||
| 52 |
Schaaf Drugs, LLC
Top agencies
|
$1,522,263 | ||
| 53 | $1,390,565 | |||
| 54 | $1,257,796 | |||
| 55 |
Melling LLC
Top agencies
|
$1,231,578 | ||
| 56 | $1,223,169 | |||
| 57 | $1,105,863 | |||
| 58 |
Johnson & Johnson
|
$1,089,672 | ||
| 59 |
Valneva Usa, Inc.
|
$1,036,397 | ||
| 60 | $959,715 | |||
| 61 |
Priority Healthcare Distribution Inc.
|
$950,394 | ||
| 62 |
Merz Pharmaceuticals LLC
Top agencies
|
$853,397 | ||
| 63 | $825,142 | |||
| 64 | $813,512 | |||
| 65 | $803,905 | |||
| 66 | $773,470 | |||
| 67 |
Astrazeneca Pharmaceuticals LP
Top agencies
|
$733,352 | ||
| 68 |
INO Therapeutics LLC
|
$715,313 | ||
| 69 | $709,217 | |||
| 70 | $700,993 | |||
| 71 |
Pine Pharmaceuticals LLC
|
$674,219 | ||
| 72 | $558,114 | |||
| 73 |
The Janz Corp
Top agencies
|
$553,970 | ||
| 74 | $530,328 | |||
| 75 | $526,461 | |||
| 76 |
Curium US Holdings LLC
|
$513,180 | ||
| 77 |
Regimed Medical
Top agencies
|
$495,100 | ||
| 78 |
CSL Behring L.L.C.
Top agencies
|
$492,045 | ||
| 79 | $486,480 | |||
| 80 | $472,962 | |||
| 81 | $447,953 | |||
| 82 |
Topeka Hospital, LLC
Top agencies
|
$440,058 | ||
| 83 |
Autolus Inc.
Top agencies
|
$401,005 | ||
| 84 | $393,759 | |||
| 85 |
Grifols Diagnostic Solutions Inc.
Top agencies
|
$377,947 | ||
| 86 |
Anbex Inc.
Top agencies
|
$373,721 | ||
| 87 |
Detectachem Inc.
Top agencies
|
$372,660 | ||
| 88 | $357,803 | |||
| 89 | $350,000 | |||
| 90 |
Ucb, Inc.
Top agencies
|
$339,454 | ||
| 91 | $337,025 | |||
| 92 |
Kiniksa Pharmaceuticals Ltd
Top agencies
|
$330,119 | ||
| 93 | $318,917 | |||
| 94 | $300,000 | |||
| 95 | $289,027 | |||
| 96 | $288,403 | |||
| 97 |
ELI Lilly and Company
Top agencies
|
$281,860 | ||
| 98 | $268,660 | |||
| 99 | $253,356 | |||
| 100 |
Dompe U.s. Inc.
Top agencies
|
$241,160 |
Show 75 more
100 of 257 contractors listed here. See the rest on GovTribe.
How this ranking works
- Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
- Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $13.4 billion obligated before deobligations, so they never pass 100%.
- Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
- Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
- Rank changes compare with Aug 2024–Jul 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
- Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
- Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.
Quick answers
Who were the top 10 NAICS 325412 contractors in Aug 2025–Jul 2026?
1. Mckesson Corporation ($12B), 2. Emergent Biosolutions Inc. ($118M), 3. Phlow Corp. ($114M), 4. Exelan Pharmaceuticals Inc. ($106M), 5. Government of the United States ($65.5M), 6. Nighthawk Biosciences, Inc. ($55.3M), 7. Partner Therapeutics, Inc. ($50.2M), 8. Meridian Medical Technologies LLC ($46M), 9. Teva Pharmaceuticals Usa, Inc. ($42.2M), 10. Roche Holdings Inc. ($38.9M).
On GovTribe
Research every contractor on this list
- Every contract, task order and IDV they hold
- Their subsidiaries, teammates and competitors
- Open opportunities they're positioned for
- Alerts when they win new work